Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. (Q30399216)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.
scientific article

    Statements

    Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. (English)
    Adriano Arguedas
    Carolina Soley
    Arturo Abdelnour
    Victor Sales
    Kelly Lindert
    Giovanni Della Cioppa
    Ralf Clemens
    Costa Rican H1N1 Vaccine Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit